Key Insights

Highlights

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Active Sponsors

  • National Science and Technology Council, Taiwan1
  • National Health Research Institutes, Taiwan1
  • National Taiwan University Hospital1

Top Investigators

Related Conditions

  • Hpv1
  • Human Papillomavirus1
  • Acrochordon1
  • Soft Fibroma1

Activity Timeline